跳至主要内容
临床试验/EUCTR2012-001886-33-IT
EUCTR2012-001886-33-IT进行中(未招募)1 期

Randomized, Controlled, Parallel Group, Double Blind Trial to Compare the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures Using a 2x2 Factorial Design in Patients Undergoing Laparoscopic Cholecystectomy (Protocol No. MK- 8616-076-00 also known as SCH 900616, P07982) - Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions.

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.0 个研究点目标入组 127 人开始时间: 2012年11月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
127

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Subjects must be: Males/Females = 18 yrs; ASA (American Society of Anesthesiologists) Class 1, 2 or 3; scheduled for laparoscopic cholecystectomy (standard 4-hole) procedure under general anesthesia with total intravenous anesthesia (TIVA) using propofol and remifentanil and is expected to undergo rocuronium-induced neuromuscular blockade for endotracheal intubation and require active reversal of neuromuscular blockade.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • Subjects with neuromuscular disorders that may affect neuromuscular blockade and/or assessments will be excluded from this study, in addition subjects who cannot meeting general standards for anesthesia trials (inability to intubate, renal/hepatic dysfunction, allergies to general anesthesia medications, malignant hyperthermia, interactions with toremifene/fusidic acid, pregnant patients, previous enrollment in trials or relation to staff) will also be excluded.

研究者

相似试验

进行中(未招募)
不适用
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsPatients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockadeMedDRA version: 14.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865
EUCTR2012-001886-33-FIMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
进行中(未招募)
不适用
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions
EUCTR2012-001886-33-ATMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
进行中(未招募)
不适用
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsPatients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockadeMedDRA version: 16.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865
EUCTR2012-001886-33-DEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
进行中(未招募)
1 期
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions
EUCTR2012-001886-33-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.127
已完成
不适用
Randomized, Double Blind, Parallel Group, Controlled with Placebo Study performed Under Internal Blind Conditions whose Purpose is to Examine the Safety, Tolerability and Efficacy of MK-0869 for the Prevention of Nausea and Vomiting Induced by Chemotherapy Associated with Administration of High doses of Cisplatin.-C80 Malignant neoplasm, without specification of siteMalignant neoplasm, without specification of siteC80
PER-009-01MERCK SHARP & DOHME PERU S.R.L.,